Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants
Clinical trial NCT06824207 · COMPLETED
Trial details
- NCT number
- NCT06824207
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-13
- Primary completion
- 2026-05-19
- Enrollment
- 2400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.